SARS-CoV-2 spike protein alone may cause lung damage
New mouse model makes it easier and safer to study COVID-19 lung injuryCredit: Pavel Solopov, Old Dominion University Using a ...
Tag: Infectious/Emerging Diseases
Gene changes might explain long-haul COVID-19 symptoms
Airway cells exposed to SARS-CoV-2 spike protein exhibited persisting changes in gene expressionCredit: Julie A. Forrest Results from a new ...
Loss of fauna in tropical forests impedes achieving Sustainable Development Goals
Credit: Photo by Torsten Krause (LUCSUS) The current loss of biological diversity is unprecedented and species extinctions exceed the estimated ...
SARS-CoV-2 curtails immune response in the gut
Scientists transform human intestinal cells into 'mini guts' to follow infection processCredit: Mohammed Shahraz, Sergio Triana/EMBL; Camila Metz-Zumaran/Heidelberg University In ...
Pandemic significantly increases insomnia in health care workers
Credit: Augusta University The COVID pandemic appears to have triggered about a 44% increase in insomnia disorder among health care ...
New rapid COVID-19 test the result of university-industry partnership
Innovative platform pairs mass spectrometry with machine learningCredit: UC Davis Health A partnership between UC Davis and Maurice J. Gallagher, ...
MIT PRESS publishes new book on contact-tracing apps and public health
Susan Landau's 'People Count'Credit: The MIT PRESS, 2021. How do you stop a pandemic before a vaccine arrives? Contact tracing ...
Cell study suggests pesticide exposure may increase COVID-19 susceptibility
Inflammation-induced mechanism might be linked with higher infection risk for veterans and people with metabolic disordersCredit: Saurabh Chatterjee, PhD, University ...
New testing strategy can speed up COVID-19 test results for healthcare workers
In The Journal of Molecular Diagnostics investigators share a new methodology for testing pooled samples that maximizes the proportion of ...
COVID-19 vaccine responses to be studied in people with immune deficits
Enrollment begins at NIH Clinical CenterCredit: NIAID A study assessing how people with immune system deficiencies or dysregulations respond to ...
High dose of vitamin D fails to improve condition of moderate to severe COVID-19 patients
A clinical trial was conducted with 240 patients who were given 200,000 IU of vitamin D3 on admission to hospital. ...
COVID-19 vaccine development built on >$17 billion in NIH funding for vaccine technologies
Broad foundation of NIH-funded research for enabling technologies prior to pandemic provided a tool kit for rapid development of COVID ...
Stress test finds cracks in the resistance of harmful hospital bugs
Credit: John Innes Centre Research has identified critical factors that enable dangerous bacteria to spread disease by surviving on surfaces ...
Among COVID-19 survivors, an increased risk of death, serious illness
Major study details numerous long-term effects of COVID-19, pointing to massive health burdenCredit: Sara Moser As the COVID-19 pandemic has ...
Study of ‘breakthrough’ cases suggests COVID testing may be here to stay
Credit: Matthew Septimus/The Rockefeller University In rare cases, people who have been fully vaccinated against COVID and are immune to ...
Clinical trial of therapeutics for severely ill hospitalized COVID-19 patients begins
Patients with acute respiratory failure may now enroll in NIH-sponsored trialCredit: NIAID A new Phase 3 trial to test the ...
Individuals in lower-income US counties or high support for former President Trump continue to be less likely to socially distance
A new nearly yearlong study in the American Journal of Preventive Medicine finds that lower-income and Republican-leaning communities are less ...
Fighting harmful bacteria with nanoparticles
New weapons against antibiotic resistanceCredit: Empa In the arms race "mankind against bacteria", bacteria are currently ahead of us. Our ...
Collaboration with Johnson & Johnson Innovation to jump-start search for new malaria drugs
Credit: WEHI, Australia Potential new antimalarial drug candidates are being developed through an extended drug-discovery collaboration between Australian medical research ...
Large NIH clinical trial will test polyclonal antibody therapeutic for COVID-19
Credit: NIAID A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has ...